CClinicalTrials.gg
RecruitingNCT05533528Updated Feb 19, 2026

Periodontal Granulation Tissue Preservation in Surgical Periodontitis Treatment

An interventional study of periodontal surgery in Periodontal Pocket, Periodontal Diseases and Periodontal Bone Loss, sponsored by Universidad de Murcia. Recruiting at 1 site in Spain. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-02-19.

Sponsored by Universidad de Murcia · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 4 months after the study started (first participant enrolled May 2022, registered Sep 2022).
  • Started May 2022; still recruiting 4 years 5 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
25
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The objective of this study will be to evaluate a new protocol for the surgical treatment of periodontal disease with two novelties: to make a single incision in the midline of the interproximal area to respect the vascular supply and preserve the granulation tissue with regenerative potential.

The investigators will carry out a controlled and randomized clinical trial with a control group (n=25; modified Kirkland flap) and a test group (n=25; experimental surgical protocol: incision in the mid-interproximal area of the papilla and preservation of the granulation tissue).

Clinical parameters will be taken at the time of surgery and 12 months follow-up: bleeding on probing (BoP), clinical attachment level (CAL), residual probing depth (rPD),Probing pocket depth reduction (PPDr), recession (REC), interproximal gingival recession (iGR), width of keratinized gingiva (KT), gain of supra-alveolar clinical attachment (SUPRA-AG), early wound healing index (EHI).

02

Conditions studied

  • Periodontal Pocket
  • Periodontal Diseases
  • Periodontal Bone Loss
03

In context

Periodontal Pocket

126 studies on the registry are indexed under Periodontal Pocket; 36 are open to participants now.

This study's planned enrollment of 25 is below the median of 30 across 109 interventional studies indexed under Periodontal Pocket.

Browse Periodontal Pocket studies →

Lead sponsor

Universidad de Murcia is the lead sponsor of 77 studies on the registry; 16 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Stage III or IV periodontitis, including all grades.
  • Unresolved deep pockets (probing pocket depth [PPD] >5 mm + BoP) 4 to 6 weeks after non-surgical treatment.
  • Interproximal plaque index \<35% maintained during periodontal treatment and maintenance.
  • Adherence to periodontal maintenance appointments.

Exclusion criteria

Exclusion Criteria:

  • Systemic disease contraindicating periodontal surgery.
  • Teeth with incorrect endodontic treatment or restoration.
  • Stage I or II periodontitis.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
25 participants (estimated)

Study arms

  • Active comparator
    Control

    Access flap periodontal surgery

    Procedure: periodontal surgery

  • Experimental
    Test

    Access flap periodontal surgery and periodontal granulation tissue debridement.

    Procedure: periodontal surgery

Interventions

  • Procedureperiodontal surgery

    A sulcular incision will be made in the affected teeth, followed by an incision from the buccal aspect in the mid-portion of the interproximal tissues The buccal and lingual flaps will be elevated. For periodontal granulation tissue preservation group, the soft tissues covering the alveolar crest will be prepared. A third incision will separate the pocket epithelium from the soft tissue (granulation tissue) attached to the bone. The pocket epithelium will be removed. The root surfaces will be carefully scaled and planed in both groups. Ethylenediaminetetraacetic acid (24%) will be applied to the root surfaces and removed after 2 minutes with abundant saline solution. In the experimental group, the preserved attached soft tissue and the space between it and the root surface will be irrigated with 10% polyvinylpyrrolidone-iodine. Finally, the flaps will be positioned and sutured.

06

What researchers measure

Primary outcomes

  1. Clinical attachment gain (CAG)

    Clinical attachment gain

    Time frame: 12 months

Secondary outcomes

  1. rPD

    residual probing depth

    Time frame: 12 months

  2. PPDr

    Probing pocket depth reduction

    Time frame: 12 months

  3. iGR

    interproximal gingival recession

    Time frame: 12 months

  4. Early Healing Index (EHI)

    Five types of early healing will be recorded: EHI 1, complete closure of the incision line, with no fibrin; EHI 2-3, formation of a thin line or a fibrin clot in the incision area, respectively; EHI 4-5, incomplete closure with partial necrosis or necrosis of the incision area, respectively.

    Time frame: 1 week

  5. SUPRA-AG

    Supra-alveolar attachment gain

    Time frame: 12 months

07

Study locations

1 of 1 sites recruiting
  • Centro Odontologico Del Sureste Slp
    Murcia, 30007, Spain
    Recruiting
08

References and documents

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 19, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05533528
Lead sponsor
Universidad de Murcia
Responsible party
Antonio José Ortiz Ruiz, MD (Professor and researcher, Universidad de Murcia) — Principal investigator
First posted
Sep 9, 2022
Start date
May 3, 2022
Primary completion
Dec 22, 2026 (estimated)
Completion
Feb 1, 2027 (estimated)
Last update
Feb 19, 2026

Study contacts

Antonio J Ortiz-Ruiz, MD
Contact
ajortiz@um.es
+34 868888581
José A Moreno-Rodríguez, DDS
Contact
joseantonio171087@hotmail.com
+34 620538483

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion